151 related articles for article (PubMed ID: 11706939)
1. Small cell architecture--a histological equivalent of EGFR amplification in glioblastoma multiforme?
Burger PC; Pearl DK; Aldape K; Yates AJ; Scheithauer BW; Passe SM; Jenkins RB; James CD
J Neuropathol Exp Neurol; 2001 Nov; 60(11):1099-104. PubMed ID: 11706939
[TBL] [Abstract][Full Text] [Related]
2. Chromogenic in situ hybridization accurately identifies EGFR amplification in small cell glioblastoma multiforme, a common subtype of primary GBM.
Quezado M; Ronchetti R; Rapkiewicz A; Santi M; Blumenthal DT; Rushing EJ
Clin Neuropathol; 2005; 24(4):163-9. PubMed ID: 16033132
[TBL] [Abstract][Full Text] [Related]
3. Characterization of glioblastomas in young adults.
Kleinschmidt-DeMasters BK; Meltesen L; McGavran L; Lillehei KO
Brain Pathol; 2006 Oct; 16(4):273-86. PubMed ID: 17107596
[TBL] [Abstract][Full Text] [Related]
4. Paradoxical relationship between the degree of EGFR amplification and outcome in glioblastomas.
Hobbs J; Nikiforova MN; Fardo DW; Bortoluzzi S; Cieply K; Hamilton RL; Horbinski C
Am J Surg Pathol; 2012 Aug; 36(8):1186-93. PubMed ID: 22472960
[TBL] [Abstract][Full Text] [Related]
5. Low-level microsatellite instability phenotype in sporadic glioblastoma multiforme.
Martinez R; Schackert HK; Appelt H; Plaschke J; Baretton G; Schackert G
J Cancer Res Clin Oncol; 2005 Feb; 131(2):87-93. PubMed ID: 15672285
[TBL] [Abstract][Full Text] [Related]
6. Somatic copy number alterations are associated with EGFR amplification and shortened survival in patients with primary glioblastoma.
Muñoz-Hidalgo L; San-Miguel T; Megías J; Monleón D; Navarro L; Roldán P; Cerdá-Nicolás M; López-Ginés C
Neoplasia; 2020 Jan; 22(1):10-21. PubMed ID: 31751860
[TBL] [Abstract][Full Text] [Related]
7. Comparison of automated silver enhanced in situ hybridization and fluorescence in situ hybridization for evaluation of epidermal growth factor receptor status in human glioblastomas.
Gaiser T; Waha A; Moessler F; Bruckner T; Pietsch T; von Deimling A
Mod Pathol; 2009 Sep; 22(9):1263-71. PubMed ID: 19525925
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastoma.
Lassman AB; Aldape KD; Ansell PJ; Bain E; Curran WJ; Eoli M; French PJ; Kinoshita M; Looman J; Mehta M; Muragaki Y; Narita Y; Ocampo C; Roberts-Rapp L; Song M; Vogelbaum MA; Walenkamp AME; Wang TJC; Zhang P; van den Bent MJ
J Neurooncol; 2019 Aug; 144(1):205-210. PubMed ID: 31273577
[TBL] [Abstract][Full Text] [Related]
9. Pediatric glioblastomas: a histopathological and molecular genetic study.
Suri V; Das P; Pathak P; Jain A; Sharma MC; Borkar SA; Suri A; Gupta D; Sarkar C
Neuro Oncol; 2009 Jun; 11(3):274-80. PubMed ID: 18981259
[TBL] [Abstract][Full Text] [Related]
10. Activity of anti-epidermal growth factor receptor monoclonal antibody C225 against glioblastoma multiforme.
Eller JL; Longo SL; Hicklin DJ; Canute GW
Neurosurgery; 2002 Oct; 51(4):1005-13; discussion 1013-4. PubMed ID: 12234411
[TBL] [Abstract][Full Text] [Related]
11. Expression of activated epidermal growth factor receptors, Ras-guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimens.
Feldkamp MM; Lala P; Lau N; Roncari L; Guha A
Neurosurgery; 1999 Dec; 45(6):1442-53. PubMed ID: 10598712
[TBL] [Abstract][Full Text] [Related]
12. Frequency of NFKBIA deletions is low in glioblastomas and skewed in glioblastoma neurospheres.
Patanè M; Porrati P; Bottega E; Morosini S; Cantini G; Girgenti V; Rizzo A; Eoli M; Pollo B; Sciacca FL; Pellegatta S; Finocchiaro G
Mol Cancer; 2013 Dec; 12():160. PubMed ID: 24330732
[TBL] [Abstract][Full Text] [Related]
13. Concurrent EGFR amplification and TP-53 mutation in glioblastomas.
Gil-Benso R; Lopez-Gines C; Benito R; López-Guerrero JA; Callaghan RC; Pellín A; Roldán P; Cerdá-Nicolas M
Clin Neuropathol; 2007; 26(5):224-31. PubMed ID: 17907599
[TBL] [Abstract][Full Text] [Related]
14. Amplification of the epidermal growth factor receptor gene in glioblastoma: an analysis of the relationship between genotype and phenotype by CISH method.
Miyanaga T; Hirato J; Nakazato Y
Neuropathology; 2008 Apr; 28(2):116-26. PubMed ID: 18021194
[TBL] [Abstract][Full Text] [Related]
15. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype.
Choe G; Park JK; Jouben-Steele L; Kremen TJ; Liau LM; Vinters HV; Cloughesy TF; Mischel PS
Clin Cancer Res; 2002 Sep; 8(9):2894-901. PubMed ID: 12231534
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response.
Szerlip NJ; Pedraza A; Chakravarty D; Azim M; McGuire J; Fang Y; Ozawa T; Holland EC; Huse JT; Jhanwar S; Leversha MA; Mikkelsen T; Brennan CW
Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3041-6. PubMed ID: 22323597
[TBL] [Abstract][Full Text] [Related]
17. Identification of molecular subtypes of glioblastoma by gene expression profiling.
Mischel PS; Shai R; Shi T; Horvath S; Lu KV; Choe G; Seligson D; Kremen TJ; Palotie A; Liau LM; Cloughesy TF; Nelson SF
Oncogene; 2003 Apr; 22(15):2361-73. PubMed ID: 12700671
[TBL] [Abstract][Full Text] [Related]
18. Predicting epidermal growth factor receptor gene amplification status in glioblastoma multiforme by quantitative enhancement and necrosis features deriving from conventional magnetic resonance imaging.
Dong F; Zeng Q; Jiang B; Yu X; Wang W; Xu J; Yu J; Li Q; Zhang M
Medicine (Baltimore); 2018 May; 97(21):e10833. PubMed ID: 29794775
[TBL] [Abstract][Full Text] [Related]
19. Amplification and overexpression of epidermal growth factor receptor gene in glioblastomas of Chinese patients correlates with patient's age but not with tumor's clinicopathological pathway.
Xie D; Zeng YX; Wang HJ; Tai LS; Wen JM; Tao Y; Ma NF; Hu L; Sham JS; Guan XY
Acta Neuropathol; 2005 Nov; 110(5):481-9. PubMed ID: 16151725
[TBL] [Abstract][Full Text] [Related]
20. Correlation between EGFR amplification and the expression of microRNA-200c in primary glioblastoma multiforme.
Serna E; Lopez-Gines C; Monleon D; Muñoz-Hidalgo L; Callaghan RC; Gil-Benso R; Martinetto H; Gregori-Romero A; Gonzalez-Darder J; Cerda-Nicolas M
PLoS One; 2014; 9(7):e102927. PubMed ID: 25058589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
